Global Cyclooxygenase 2 Inhibitor Market Growth (Status and Outlook) 2025-2031

September 2025 | 119 pages | ID: G59B4F91B505EN
LP Information

Abstracts

According to this study, the global Cyclooxygenase 2 Inhibitor market size will reach US$ million by 2031.

COX inhibitors are mostly antipyretic and analgesic anti-inflammatory drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs). COX-2 has extremely low activity in normal tissue cells, and can only be produced in large quantities when induced. It mediates pain, inflammation, and fever by promoting PG synthesis. In general, multiple adverse effects of non-steroidal anti-inflammatory drugs are believed to be related to the inhibition of COX-1. As a result, COX-2 selective inhibitors have emerged.

United States market for Cyclooxygenase 2 Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cyclooxygenase 2 Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cyclooxygenase 2 Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cyclooxygenase 2 Inhibitor players cover Pfizer, Bayer, Novartis, Merck, Sabinsa, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cyclooxygenase 2 Inhibitor Industry Forecast” looks at past sales and reviews total world Cyclooxygenase 2 Inhibitor sales in 2024, providing a comprehensive analysis by region and market sector of projected Cyclooxygenase 2 Inhibitor sales for 2025 through 2031. With Cyclooxygenase 2 Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyclooxygenase 2 Inhibitor industry.

This Insight Report provides a comprehensive analysis of the global Cyclooxygenase 2 Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cyclooxygenase 2 Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyclooxygenase 2 Inhibitor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyclooxygenase 2 Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyclooxygenase 2 Inhibitor.

This report presents a comprehensive overview, market shares, and growth opportunities of Cyclooxygenase 2 Inhibitor market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Selective Cox 2 Inhibitor
• Non-Selective Cox 2 Inhibitor

Segmentation by Application:

• Hospital
• Specialty Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Bayer
• Novartis
• Merck
• Sabinsa
• Cadila Pharmaceuticals
• Mylan
• Teva Pharmaceutical
• Alembic Pharmaceutical
• Aurobindo Pharma
• Cipla
• Torrent Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cyclooxygenase 2 Inhibitor Market Size (2020-2031)
  2.1.2 Cyclooxygenase 2 Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Cyclooxygenase 2 Inhibitor by Country/Region (2020, 2024 & 2031)
2.2 Cyclooxygenase 2 Inhibitor Segment by Type
  2.2.1 Selective Cox 2 Inhibitor
  2.2.2 Non-Selective Cox 2 Inhibitor
2.3 Cyclooxygenase 2 Inhibitor Market Size by Type
  2.3.1 Cyclooxygenase 2 Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Cyclooxygenase 2 Inhibitor Market Size Market Share by Type (2020-2025)
2.4 Cyclooxygenase 2 Inhibitor Segment by Application
  2.4.1 Hospital
  2.4.2 Specialty Clinic
  2.4.3 Others
2.5 Cyclooxygenase 2 Inhibitor Market Size by Application
  2.5.1 Cyclooxygenase 2 Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Cyclooxygenase 2 Inhibitor Market Size Market Share by Application (2020-2025)

3 CYCLOOXYGENASE 2 INHIBITOR MARKET SIZE BY PLAYER

3.1 Cyclooxygenase 2 Inhibitor Market Size Market Share by Player
  3.1.1 Global Cyclooxygenase 2 Inhibitor Revenue by Player (2020-2025)
  3.1.2 Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Player (2020-2025)
3.2 Global Cyclooxygenase 2 Inhibitor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CYCLOOXYGENASE 2 INHIBITOR BY REGION

4.1 Cyclooxygenase 2 Inhibitor Market Size by Region (2020-2025)
4.2 Global Cyclooxygenase 2 Inhibitor Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cyclooxygenase 2 Inhibitor Market Size Growth (2020-2025)
4.4 APAC Cyclooxygenase 2 Inhibitor Market Size Growth (2020-2025)
4.5 Europe Cyclooxygenase 2 Inhibitor Market Size Growth (2020-2025)
4.6 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025)
5.2 Americas Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025)
5.3 Americas Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cyclooxygenase 2 Inhibitor Market Size by Region (2020-2025)
6.2 APAC Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025)
6.3 APAC Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025)
7.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025)
7.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cyclooxygenase 2 Inhibitor by Region (2020-2025)
8.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025)
8.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CYCLOOXYGENASE 2 INHIBITOR MARKET FORECAST

10.1 Global Cyclooxygenase 2 Inhibitor Forecast by Region (2026-2031)
  10.1.1 Global Cyclooxygenase 2 Inhibitor Forecast by Region (2026-2031)
  10.1.2 Americas Cyclooxygenase 2 Inhibitor Forecast
  10.1.3 APAC Cyclooxygenase 2 Inhibitor Forecast
  10.1.4 Europe Cyclooxygenase 2 Inhibitor Forecast
  10.1.5 Middle East & Africa Cyclooxygenase 2 Inhibitor Forecast
10.2 Americas Cyclooxygenase 2 Inhibitor Forecast by Country (2026-2031)
  10.2.1 United States Market Cyclooxygenase 2 Inhibitor Forecast
  10.2.2 Canada Market Cyclooxygenase 2 Inhibitor Forecast
  10.2.3 Mexico Market Cyclooxygenase 2 Inhibitor Forecast
  10.2.4 Brazil Market Cyclooxygenase 2 Inhibitor Forecast
10.3 APAC Cyclooxygenase 2 Inhibitor Forecast by Region (2026-2031)
  10.3.1 China Cyclooxygenase 2 Inhibitor Market Forecast
  10.3.2 Japan Market Cyclooxygenase 2 Inhibitor Forecast
  10.3.3 Korea Market Cyclooxygenase 2 Inhibitor Forecast
  10.3.4 Southeast Asia Market Cyclooxygenase 2 Inhibitor Forecast
  10.3.5 India Market Cyclooxygenase 2 Inhibitor Forecast
  10.3.6 Australia Market Cyclooxygenase 2 Inhibitor Forecast
10.4 Europe Cyclooxygenase 2 Inhibitor Forecast by Country (2026-2031)
  10.4.1 Germany Market Cyclooxygenase 2 Inhibitor Forecast
  10.4.2 France Market Cyclooxygenase 2 Inhibitor Forecast
  10.4.3 UK Market Cyclooxygenase 2 Inhibitor Forecast
  10.4.4 Italy Market Cyclooxygenase 2 Inhibitor Forecast
  10.4.5 Russia Market Cyclooxygenase 2 Inhibitor Forecast
10.5 Middle East & Africa Cyclooxygenase 2 Inhibitor Forecast by Region (2026-2031)
  10.5.1 Egypt Market Cyclooxygenase 2 Inhibitor Forecast
  10.5.2 South Africa Market Cyclooxygenase 2 Inhibitor Forecast
  10.5.3 Israel Market Cyclooxygenase 2 Inhibitor Forecast
  10.5.4 Turkey Market Cyclooxygenase 2 Inhibitor Forecast
10.6 Global Cyclooxygenase 2 Inhibitor Forecast by Type (2026-2031)
10.7 Global Cyclooxygenase 2 Inhibitor Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Cyclooxygenase 2 Inhibitor Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Cyclooxygenase 2 Inhibitor Product Offered
  11.1.3 Pfizer Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Bayer
  11.2.1 Bayer Company Information
  11.2.2 Bayer Cyclooxygenase 2 Inhibitor Product Offered
  11.2.3 Bayer Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bayer Main Business Overview
  11.2.5 Bayer Latest Developments
11.3 Novartis
  11.3.1 Novartis Company Information
  11.3.2 Novartis Cyclooxygenase 2 Inhibitor Product Offered
  11.3.3 Novartis Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Novartis Main Business Overview
  11.3.5 Novartis Latest Developments
11.4 Merck
  11.4.1 Merck Company Information
  11.4.2 Merck Cyclooxygenase 2 Inhibitor Product Offered
  11.4.3 Merck Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Merck Main Business Overview
  11.4.5 Merck Latest Developments
11.5 Sabinsa
  11.5.1 Sabinsa Company Information
  11.5.2 Sabinsa Cyclooxygenase 2 Inhibitor Product Offered
  11.5.3 Sabinsa Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sabinsa Main Business Overview
  11.5.5 Sabinsa Latest Developments
11.6 Cadila Pharmaceuticals
  11.6.1 Cadila Pharmaceuticals Company Information
  11.6.2 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product Offered
  11.6.3 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Cadila Pharmaceuticals Main Business Overview
  11.6.5 Cadila Pharmaceuticals Latest Developments
11.7 Mylan
  11.7.1 Mylan Company Information
  11.7.2 Mylan Cyclooxygenase 2 Inhibitor Product Offered
  11.7.3 Mylan Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Mylan Main Business Overview
  11.7.5 Mylan Latest Developments
11.8 Teva Pharmaceutical
  11.8.1 Teva Pharmaceutical Company Information
  11.8.2 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Product Offered
  11.8.3 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Teva Pharmaceutical Main Business Overview
  11.8.5 Teva Pharmaceutical Latest Developments
11.9 Alembic Pharmaceutical
  11.9.1 Alembic Pharmaceutical Company Information
  11.9.2 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product Offered
  11.9.3 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Alembic Pharmaceutical Main Business Overview
  11.9.5 Alembic Pharmaceutical Latest Developments
11.10 Aurobindo Pharma
  11.10.1 Aurobindo Pharma Company Information
  11.10.2 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product Offered
  11.10.3 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Aurobindo Pharma Main Business Overview
  11.10.5 Aurobindo Pharma Latest Developments
11.11 Cipla
  11.11.1 Cipla Company Information
  11.11.2 Cipla Cyclooxygenase 2 Inhibitor Product Offered
  11.11.3 Cipla Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Cipla Main Business Overview
  11.11.5 Cipla Latest Developments
11.12 Torrent Pharmaceuticals
  11.12.1 Torrent Pharmaceuticals Company Information
  11.12.2 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product Offered
  11.12.3 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Torrent Pharmaceuticals Main Business Overview
  11.12.5 Torrent Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cyclooxygenase 2 Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cyclooxygenase 2 Inhibitor Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Selective Cox 2 Inhibitor
Table 4. Major Players of Non-Selective Cox 2 Inhibitor
Table 5. Cyclooxygenase 2 Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Cyclooxygenase 2 Inhibitor Market Size Market Share by Type (2020-2025)
Table 8. Cyclooxygenase 2 Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Cyclooxygenase 2 Inhibitor Market Size Market Share by Application (2020-2025)
Table 11. Global Cyclooxygenase 2 Inhibitor Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Player (2020-2025)
Table 13. Cyclooxygenase 2 Inhibitor Key Players Head office and Products Offered
Table 14. Cyclooxygenase 2 Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cyclooxygenase 2 Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Cyclooxygenase 2 Inhibitor Market Size Market Share by Region (2020-2025)
Table 19. Global Cyclooxygenase 2 Inhibitor Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Cyclooxygenase 2 Inhibitor Market Size Market Share by Country (2020-2025)
Table 23. Americas Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Cyclooxygenase 2 Inhibitor Market Size Market Share by Type (2020-2025)
Table 25. Americas Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Cyclooxygenase 2 Inhibitor Market Size Market Share by Application (2020-2025)
Table 27. APAC Cyclooxygenase 2 Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Cyclooxygenase 2 Inhibitor Market Size Market Share by Region (2020-2025)
Table 29. APAC Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Cyclooxygenase 2 Inhibitor Market Size Market Share by Country (2020-2025)
Table 33. Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cyclooxygenase 2 Inhibitor
Table 39. Key Market Challenges & Risks of Cyclooxygenase 2 Inhibitor
Table 40. Key Industry Trends of Cyclooxygenase 2 Inhibitor
Table 41. Global Cyclooxygenase 2 Inhibitor Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Cyclooxygenase 2 Inhibitor Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Cyclooxygenase 2 Inhibitor Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Cyclooxygenase 2 Inhibitor Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Pfizer Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 46. Pfizer Cyclooxygenase 2 Inhibitor Product Offered
Table 47. Pfizer Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Pfizer Main Business
Table 49. Pfizer Latest Developments
Table 50. Bayer Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 51. Bayer Cyclooxygenase 2 Inhibitor Product Offered
Table 52. Bayer Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Bayer Main Business
Table 54. Bayer Latest Developments
Table 55. Novartis Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 56. Novartis Cyclooxygenase 2 Inhibitor Product Offered
Table 57. Novartis Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Merck Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 61. Merck Cyclooxygenase 2 Inhibitor Product Offered
Table 62. Merck Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Merck Main Business
Table 64. Merck Latest Developments
Table 65. Sabinsa Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 66. Sabinsa Cyclooxygenase 2 Inhibitor Product Offered
Table 67. Sabinsa Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sabinsa Main Business
Table 69. Sabinsa Latest Developments
Table 70. Cadila Pharmaceuticals Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 71. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product Offered
Table 72. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Cadila Pharmaceuticals Main Business
Table 74. Cadila Pharmaceuticals Latest Developments
Table 75. Mylan Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 76. Mylan Cyclooxygenase 2 Inhibitor Product Offered
Table 77. Mylan Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Mylan Main Business
Table 79. Mylan Latest Developments
Table 80. Teva Pharmaceutical Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 81. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Product Offered
Table 82. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Teva Pharmaceutical Main Business
Table 84. Teva Pharmaceutical Latest Developments
Table 85. Alembic Pharmaceutical Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 86. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product Offered
Table 87. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Alembic Pharmaceutical Main Business
Table 89. Alembic Pharmaceutical Latest Developments
Table 90. Aurobindo Pharma Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 91. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product Offered
Table 92. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Aurobindo Pharma Main Business
Table 94. Aurobindo Pharma Latest Developments
Table 95. Cipla Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 96. Cipla Cyclooxygenase 2 Inhibitor Product Offered
Table 97. Cipla Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Cipla Main Business
Table 99. Cipla Latest Developments
Table 100. Torrent Pharmaceuticals Details, Company Type, Cyclooxygenase 2 Inhibitor Area Served and Its Competitors
Table 101. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product Offered
Table 102. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Torrent Pharmaceuticals Main Business
Table 104. Torrent Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cyclooxygenase 2 Inhibitor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cyclooxygenase 2 Inhibitor Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cyclooxygenase 2 Inhibitor Sales Market Share by Country/Region (2024)
Figure 8. Cyclooxygenase 2 Inhibitor Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cyclooxygenase 2 Inhibitor Market Size Market Share by Type in 2024
Figure 10. Cyclooxygenase 2 Inhibitor in Hospital
Figure 11. Global Cyclooxygenase 2 Inhibitor Market: Hospital (2020-2025) & ($ millions)
Figure 12. Cyclooxygenase 2 Inhibitor in Specialty Clinic
Figure 13. Global Cyclooxygenase 2 Inhibitor Market: Specialty Clinic (2020-2025) & ($ millions)
Figure 14. Cyclooxygenase 2 Inhibitor in Others
Figure 15. Global Cyclooxygenase 2 Inhibitor Market: Others (2020-2025) & ($ millions)
Figure 16. Global Cyclooxygenase 2 Inhibitor Market Size Market Share by Application in 2024
Figure 17. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Player in 2024
Figure 18. Global Cyclooxygenase 2 Inhibitor Market Size Market Share by Region (2020-2025)
Figure 19. Americas Cyclooxygenase 2 Inhibitor Market Size 2020-2025 ($ millions)
Figure 20. APAC Cyclooxygenase 2 Inhibitor Market Size 2020-2025 ($ millions)
Figure 21. Europe Cyclooxygenase 2 Inhibitor Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size 2020-2025 ($ millions)
Figure 23. Americas Cyclooxygenase 2 Inhibitor Value Market Share by Country in 2024
Figure 24. United States Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Cyclooxygenase 2 Inhibitor Market Size Market Share by Region in 2024
Figure 29. APAC Cyclooxygenase 2 Inhibitor Market Size Market Share by Type (2020-2025)
Figure 30. APAC Cyclooxygenase 2 Inhibitor Market Size Market Share by Application (2020-2025)
Figure 31. China Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 35. India Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Cyclooxygenase 2 Inhibitor Market Size Market Share by Country in 2024
Figure 38. Europe Cyclooxygenase 2 Inhibitor Market Size Market Share by Type (2020-2025)
Figure 39. Europe Cyclooxygenase 2 Inhibitor Market Size Market Share by Application (2020-2025)
Figure 40. Germany Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 41. France Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Cyclooxygenase 2 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 54. APAC Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 55. Europe Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 57. United States Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 58. Canada Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 59. Mexico Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 60. Brazil Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 61. China Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 62. Japan Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 63. Korea Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 65. India Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 66. Australia Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 67. Germany Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 68. France Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 69. UK Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 70. Italy Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 71. Russia Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 72. Egypt Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 73. South Africa Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 74. Israel Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 75. Turkey Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)
Figure 76. Global Cyclooxygenase 2 Inhibitor Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Cyclooxygenase 2 Inhibitor Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Cyclooxygenase 2 Inhibitor Market Size 2026-2031 ($ millions)